Buy Semax 30mg

Semax is a synthetic heptapeptide derived from ACTH(4-10) — a fragment of adrenocorticotropic hormone that retains cognitive effects without hormonal activity. Developed in Russia and approved for clinical use in stroke recovery and transient ischemic attack, Semax has a 25-year clinical safety record and extensive nootropic research base.

▸BDNF and NGF Upregulation

Semax's most significant mechanism for nootropic users: it rapidly increases BDNF (Brain-Derived Neurotrophic Factor) and NGF (Nerve Growth Factor) in the hippocampus and prefrontal cortex within hours of administration. These neurotrophins support synaptogenesis, memory consolidation, and protection of existing neurons. Chronic Semax use appears to produce lasting improvements in neuroplasticity markers.

▸Clinical Use in Neurological Recovery

Russian clinical protocols use Semax for ischemic stroke recovery, where it reduces neurological deficit severity and accelerates functional recovery compared to standard care. The neuroprotective mechanism involves reduced glutamate excitotoxicity and improved cerebral blood flow autoregulation.

▸30mg Bulk Value

At 200-600mcg intranasal daily (typical nootropic dosing), 30mg provides 50-150 doses — 7 weeks to 5 months of supply depending on protocol. The bulk vial is significantly more economical for users who have confirmed their response and want to maintain ongoing cognitive optimization.